Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 41 | 2024 | 152 | 11.400 |
Why?
|
| Myocytes, Cardiac | 27 | 2020 | 668 | 5.500 |
Why?
|
| Myocardium | 18 | 2015 | 852 | 3.360 |
Why?
|
| Tissue Scaffolds | 14 | 2020 | 83 | 3.240 |
Why?
|
| Myocardial Contraction | 20 | 2020 | 241 | 2.950 |
Why?
|
| Bioengineering | 4 | 2024 | 15 | 2.570 |
Why?
|
| Heart, Artificial | 8 | 2017 | 46 | 2.490 |
Why?
|
| Heart | 8 | 2020 | 650 | 2.030 |
Why?
|
| Rats | 34 | 2018 | 3370 | 1.740 |
Why?
|
| Bioartificial Organs | 6 | 2017 | 10 | 1.690 |
Why?
|
| Fibrin | 10 | 2020 | 65 | 1.590 |
Why?
|
| Bioreactors | 10 | 2020 | 44 | 1.320 |
Why?
|
| Cells, Cultured | 22 | 2025 | 2885 | 1.320 |
Why?
|
| Heart Ventricles | 6 | 2018 | 749 | 1.240 |
Why?
|
| Cellular Reprogramming Techniques | 2 | 2020 | 15 | 1.240 |
Why?
|
| Adipogenesis | 3 | 2020 | 82 | 1.230 |
Why?
|
| Cellular Reprogramming | 2 | 2020 | 129 | 1.130 |
Why?
|
| Printing, Three-Dimensional | 3 | 2024 | 88 | 1.090 |
Why?
|
| Bioprosthesis | 5 | 2015 | 110 | 1.020 |
Why?
|
| Chitosan | 4 | 2018 | 27 | 1.010 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2018 | 1105 | 0.970 |
Why?
|
| Rats, Inbred F344 | 15 | 2010 | 99 | 0.960 |
Why?
|
| Ventricular Function | 4 | 2018 | 81 | 0.960 |
Why?
|
| Bioprinting | 2 | 2024 | 13 | 0.850 |
Why?
|
| Animals | 43 | 2026 | 33912 | 0.830 |
Why?
|
| Perfusion | 4 | 2009 | 209 | 0.820 |
Why?
|
| Biomedical Engineering | 2 | 2017 | 21 | 0.810 |
Why?
|
| Organ Culture Techniques | 2 | 2016 | 140 | 0.740 |
Why?
|
| Purkinje Cells | 1 | 2024 | 164 | 0.740 |
Why?
|
| Stress, Mechanical | 6 | 2026 | 178 | 0.740 |
Why?
|
| Purkinje Fibers | 1 | 2020 | 7 | 0.650 |
Why?
|
| Aortic Valve | 3 | 2022 | 455 | 0.620 |
Why?
|
| Cell Culture Techniques | 7 | 2020 | 274 | 0.600 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 83 | 0.580 |
Why?
|
| Aorta | 3 | 2011 | 521 | 0.540 |
Why?
|
| Biomedical Research | 3 | 2008 | 561 | 0.530 |
Why?
|
| Regeneration | 3 | 2015 | 230 | 0.530 |
Why?
|
| Electrocardiography | 3 | 2018 | 970 | 0.520 |
Why?
|
| Leadership | 3 | 2008 | 255 | 0.510 |
Why?
|
| Biocompatible Materials | 5 | 2020 | 108 | 0.500 |
Why?
|
| Artificial Organs | 1 | 2016 | 11 | 0.500 |
Why?
|
| Pulsatile Flow | 1 | 2016 | 110 | 0.480 |
Why?
|
| Action Potentials | 2 | 2017 | 476 | 0.480 |
Why?
|
| Animals, Newborn | 8 | 2017 | 1021 | 0.460 |
Why?
|
| Endocardium | 2 | 2026 | 45 | 0.460 |
Why?
|
| Equipment Design | 6 | 2015 | 512 | 0.440 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 261 | 0.430 |
Why?
|
| Gels | 4 | 2017 | 59 | 0.430 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2015 | 75 | 0.420 |
Why?
|
| Creativity | 3 | 2008 | 12 | 0.410 |
Why?
|
| Endothelial Cells | 3 | 2026 | 523 | 0.410 |
Why?
|
| Group Processes | 3 | 2008 | 48 | 0.400 |
Why?
|
| Cell Survival | 4 | 2024 | 826 | 0.400 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 232 | 0.400 |
Why?
|
| Angina Pectoris | 1 | 2013 | 56 | 0.390 |
Why?
|
| Sternotomy | 1 | 2013 | 41 | 0.390 |
Why?
|
| Electric Stimulation | 5 | 2020 | 234 | 0.390 |
Why?
|
| Tissue Culture Techniques | 3 | 2010 | 63 | 0.390 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 1168 | 0.380 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 171 | 0.320 |
Why?
|
| Vascular Grafting | 1 | 2011 | 51 | 0.320 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2011 | 223 | 0.320 |
Why?
|
| Muscle, Smooth | 1 | 2011 | 116 | 0.320 |
Why?
|
| Coronary Artery Bypass | 1 | 2013 | 515 | 0.300 |
Why?
|
| Isoproterenol | 3 | 2020 | 85 | 0.290 |
Why?
|
| Calcium | 3 | 2009 | 1010 | 0.290 |
Why?
|
| Environment Design | 1 | 2008 | 16 | 0.280 |
Why?
|
| Streptomycin | 1 | 2008 | 11 | 0.280 |
Why?
|
| Cell Aggregation | 1 | 2008 | 20 | 0.280 |
Why?
|
| Personnel Management | 1 | 2008 | 7 | 0.280 |
Why?
|
| Heart Failure | 3 | 2020 | 2332 | 0.280 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 999 | 0.280 |
Why?
|
| Time Management | 1 | 2008 | 8 | 0.280 |
Why?
|
| Organizational Policy | 1 | 2008 | 50 | 0.280 |
Why?
|
| Policy Making | 1 | 2008 | 63 | 0.280 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2008 | 14 | 0.270 |
Why?
|
| Body Size | 1 | 2008 | 62 | 0.270 |
Why?
|
| Cell Count | 1 | 2008 | 212 | 0.270 |
Why?
|
| Models, Cardiovascular | 2 | 2022 | 165 | 0.270 |
Why?
|
| Organizational Objectives | 1 | 2008 | 34 | 0.270 |
Why?
|
| Infusion Pumps | 1 | 2008 | 31 | 0.270 |
Why?
|
| Thyroid Hormones | 1 | 2008 | 54 | 0.270 |
Why?
|
| Humans | 28 | 2026 | 131163 | 0.270 |
Why?
|
| Heart Valves | 1 | 2008 | 52 | 0.260 |
Why?
|
| Neovascularization, Physiologic | 2 | 2008 | 197 | 0.260 |
Why?
|
| Blood Vessels | 1 | 2008 | 92 | 0.260 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2008 | 87 | 0.260 |
Why?
|
| Diffusion of Innovation | 1 | 2008 | 83 | 0.260 |
Why?
|
| Inflammation | 2 | 2025 | 1489 | 0.260 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 981 | 0.260 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2011 | 492 | 0.250 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 802 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 288 | 0.250 |
Why?
|
| Zebrafish | 1 | 2008 | 418 | 0.230 |
Why?
|
| Muscle Cells | 1 | 2005 | 24 | 0.230 |
Why?
|
| Epinephrine | 3 | 2020 | 150 | 0.230 |
Why?
|
| Time Factors | 5 | 2024 | 6196 | 0.230 |
Why?
|
| Heart Valve Prosthesis | 1 | 2008 | 303 | 0.220 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2024 | 7 | 0.220 |
Why?
|
| Spheroids, Cellular | 1 | 2024 | 59 | 0.210 |
Why?
|
| Ventricular Function, Left | 1 | 2008 | 549 | 0.210 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 95 | 0.210 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2024 | 23 | 0.200 |
Why?
|
| Cardiac Catheterization | 1 | 2008 | 630 | 0.200 |
Why?
|
| Models, Animal | 2 | 2020 | 450 | 0.200 |
Why?
|
| Electric Conductivity | 2 | 2020 | 79 | 0.190 |
Why?
|
| Angioplasty, Balloon | 1 | 2024 | 122 | 0.190 |
Why?
|
| Cooperative Behavior | 3 | 2008 | 224 | 0.190 |
Why?
|
| Muscle Contraction | 2 | 2016 | 147 | 0.180 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 167 | 0.180 |
Why?
|
| Heart-Assist Devices | 1 | 2011 | 1020 | 0.180 |
Why?
|
| Macrophages | 1 | 2024 | 667 | 0.160 |
Why?
|
| Adrenergic Agonists | 1 | 2020 | 9 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 42 | 0.150 |
Why?
|
| Cell Communication | 1 | 2020 | 188 | 0.150 |
Why?
|
| Materials Testing | 2 | 2009 | 73 | 0.140 |
Why?
|
| Membrane Potentials | 1 | 2020 | 293 | 0.140 |
Why?
|
| Regenerative Medicine | 2 | 2011 | 39 | 0.140 |
Why?
|
| Staff Development | 2 | 2008 | 50 | 0.140 |
Why?
|
| Equipment Failure Analysis | 2 | 2008 | 79 | 0.140 |
Why?
|
| Stents | 1 | 2024 | 799 | 0.140 |
Why?
|
| Gene Expression | 3 | 2017 | 1481 | 0.130 |
Why?
|
| Polymers | 2 | 2008 | 103 | 0.130 |
Why?
|
| Biomechanical Phenomena | 2 | 2008 | 279 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2323 | 0.130 |
Why?
|
| Phenotype | 3 | 2020 | 4497 | 0.120 |
Why?
|
| Motivation | 2 | 2008 | 328 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2020 | 2465 | 0.120 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1363 | 0.110 |
Why?
|
| Mechanical Phenomena | 1 | 2015 | 18 | 0.110 |
Why?
|
| Collagen Type I | 1 | 2015 | 110 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 2121 | 0.110 |
Why?
|
| Electrodes | 1 | 2015 | 82 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2020 | 2406 | 0.100 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2013 | 15 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2014 | 308 | 0.100 |
Why?
|
| Kinetics | 2 | 2020 | 1088 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2008 | 1345 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2014 | 556 | 0.090 |
Why?
|
| Aging | 1 | 2018 | 1242 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2011 | 94 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2013 | 824 | 0.080 |
Why?
|
| Thymus Gland | 1 | 2010 | 104 | 0.080 |
Why?
|
| Reoperation | 1 | 2013 | 818 | 0.080 |
Why?
|
| Mesoderm | 1 | 2010 | 106 | 0.080 |
Why?
|
| Software | 1 | 2015 | 733 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 175 | 0.080 |
Why?
|
| Ventricular Myosins | 1 | 2009 | 3 | 0.080 |
Why?
|
| Decanoates | 1 | 2009 | 3 | 0.080 |
Why?
|
| Equipment and Supplies | 1 | 2009 | 27 | 0.070 |
Why?
|
| Polyesters | 1 | 2009 | 37 | 0.070 |
Why?
|
| Fibronectins | 1 | 2009 | 99 | 0.070 |
Why?
|
| Laminin | 1 | 2009 | 66 | 0.070 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 10 | 0.070 |
Why?
|
| Sympathomimetics | 1 | 2008 | 10 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12936 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 38 | 0.070 |
Why?
|
| Male | 5 | 2024 | 64957 | 0.070 |
Why?
|
| Facility Design and Construction | 1 | 2008 | 6 | 0.070 |
Why?
|
| Cytokines | 2 | 2025 | 1339 | 0.070 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2008 | 6 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2010 | 316 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 74 | 0.070 |
Why?
|
| Ventricular Pressure | 1 | 2008 | 34 | 0.070 |
Why?
|
| Flow Injection Analysis | 1 | 2008 | 3 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 115 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2008 | 37 | 0.070 |
Why?
|
| Efficiency, Organizational | 1 | 2008 | 56 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2005 | 305 | 0.070 |
Why?
|
| Culture Media | 1 | 2008 | 171 | 0.070 |
Why?
|
| Length of Stay | 1 | 2013 | 1421 | 0.070 |
Why?
|
| Observer Variation | 1 | 2008 | 311 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 437 | 0.060 |
Why?
|
| Job Satisfaction | 1 | 2008 | 100 | 0.060 |
Why?
|
| Interdisciplinary Communication | 1 | 2008 | 129 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 325 | 0.060 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2007 | 12 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2008 | 105 | 0.060 |
Why?
|
| Silicones | 1 | 2007 | 31 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2008 | 175 | 0.060 |
Why?
|
| Female | 5 | 2024 | 70963 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 808 | 0.060 |
Why?
|
| Workload | 1 | 2008 | 151 | 0.060 |
Why?
|
| Thrombin | 1 | 2007 | 57 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1928 | 0.060 |
Why?
|
| Child | 3 | 2024 | 26341 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 242 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 83 | 0.060 |
Why?
|
| Shear Strength | 1 | 2026 | 17 | 0.060 |
Why?
|
| Snail Family Transcription Factors | 1 | 2026 | 27 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2008 | 541 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2008 | 643 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2008 | 401 | 0.060 |
Why?
|
| Poloxamer | 1 | 2024 | 14 | 0.050 |
Why?
|
| Porosity | 1 | 2024 | 41 | 0.050 |
Why?
|
| Alginates | 1 | 2024 | 24 | 0.050 |
Why?
|
| RNA | 1 | 2008 | 517 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4697 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8635 | 0.050 |
Why?
|
| Angiography | 1 | 2024 | 179 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1371 | 0.050 |
Why?
|
| Stem Cells | 1 | 2008 | 702 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2013 | 6459 | 0.050 |
Why?
|
| Middle Aged | 2 | 2013 | 28601 | 0.040 |
Why?
|
| Swine | 1 | 2025 | 1186 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2904 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17753 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2022 | 216 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 12 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2022 | 674 | 0.040 |
Why?
|
| Biomarkers | 1 | 2009 | 3385 | 0.040 |
Why?
|
| Hypoxia | 1 | 2020 | 247 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2065 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 18301 | 0.020 |
Why?
|
| Thermogravimetry | 1 | 2009 | 5 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2009 | 7 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2009 | 33 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 47 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13352 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 15110 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4686 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 849 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 423 | 0.010 |
Why?
|
| Troponin T | 1 | 2004 | 259 | 0.010 |
Why?
|